Clinical Trials

Showing trials with last updates posted in 2022.

NCT03755570 | SUSPENDED
198 participants

How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?

Study Type:
OBSERVATIONAL
Last Updated:
2022-08-02
Start Date:
2019-06-21
Completion:
2024-01-14
Conditions
  • Cognitive Impairment
  • Cognitive Change
  • Heart Failure, Systolic
  • Heart Failure
  • Cognitive Impairment, Mild
  • Left Ventricular Dysfunction
  • Left Ventricular Systolic Dysfunction
  • Systolic Dysfunction
  • Systolic Heart Failure
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT03702764 | COMPLETED
1000 participants

Coronary Plaque Geometry and Acute Coronary Syndromes

Study Type:
OBSERVATIONAL
Last Updated:
2022-08-02
Start Date:
2019-02-01
Completion:
2019-11-30
Conditions
  • Coronary Stenosis
  • Acute Coronary Syndrome
  • Acute Myocardial Infarction
  • Atherosclerosis
  • Atheromatous Plaques
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT03606330 | COMPLETED
100 participants

Systemic, Pancoronary and Local Coronary Vulnerability

Study Type:
OBSERVATIONAL
Last Updated:
2022-08-02
Start Date:
2018-10-22
Completion:
2019-10-22
Conditions
  • Coronary Stenosis
  • Acute Coronary Syndrome
  • Acute Myocardial Infarction
  • Atheromatous Plaques
  • Atheroscleroses, Coronary
  • Non-ST Elevation Myocardial Infarction (nSTEMI)
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT03395041 | COMPLETED
149 participants

Periodontal Disease, Inflammation and Acute Coronary Syndromes

Study Type:
OBSERVATIONAL
Last Updated:
2022-08-02
Start Date:
2018-05-15
Completion:
2021-01-15
Conditions
  • Coronary Stenosis
  • Periodontal Diseases
  • Acute Coronary Syndrome
  • Non-ST Elevation Myocardial Infarction
  • Unstable Angina
  • Acute Myocardial Infarction
  • Atherosclerosis
  • Atheromatous Plaques
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT03226301 | ACTIVE_NOT_RECRUITING | PHASE2
230 participants

A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-02
Start Date:
2017-06-23
Completion:
2021-06-30
Conditions
  • Chronic Lymphocytic Leukemia in Relapse
  • Chronic Lymphocytic Leukemia in Remission
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page